No. | Sex/Age(yr) | Co-Morbidities | Aneurysm Type/Location | Sizea (Largest Diameter, mm) | Previous Treatment | No. of PED | DAT Regimen | Time to Bleed (days) | Hematoma Sizeb (mm) | Outcome (mRS) |
---|---|---|---|---|---|---|---|---|---|---|
1 | M/53 | Smoker (40 pack-years) | Fusiform/R MCA | 21 | Clipped | 1 | ASA, 325 mg; clopidogrel, 75 mg | 1 | 49 × 21 | 0 |
Started 5 days before | ||||||||||
2 | F/49 | Smoker (68 pack-years) | Saccular/L supraclinoid ICA | 5 | None | 1 | ASA, 325 mg; clopidogrel, 75 mg | 2 | 36 × 23 | 2 |
Asthma | Started 5 days before | |||||||||
3 | F/67 | HTN | Saccular/R supraclinoid ICA | 10 | PED (1) | 2 | Patient on DAT because of previous PED | 1 | 72 × 61 | 4 |
ASA, 325 mg; clopidogrel, 75 mg | ||||||||||
4 | F/70 | HTN | Saccular/R supraclinoid ICA | 9 | Coiled | 1 | Clopidogrel, 75 mg | 6 | 70 × 49 | 6 |
Heparin IV | ||||||||||
Progressive aspirin desensitization |
Note:—L indicates left; R, right; ASA, acetylsalicylic acid; HTN, hypertension.
Size of the filling portion of the aneurysm as seen on angiography, measured in the single largest diameter.
Size measured as the largest oblique diameters on axial CT images.